Page 444 - Clinical Immunology_ Principles and Practice ( PDFDrive )

424 ParT ThrEE Host Defenses to Infectious Agents

25. de Sousa Mda G, Belda W Jr, Spina R, et al. Topical application of 37. Puel A, Cypowyj S, Bustamante J, et al. Chronic mucocutaneous
imiquimod as a treatment for chromoblastomycosis. Clin Infect Dis candidiasis in humans with inborn errors of interleukin-17 immunity.
2014;58(12):1734–7. Science 2011;332(6025):65–8.
26. Underhill DM, Pearlman E. Immune interactions with pathogenic and 38. Ferwerda B, Ferwerda G, Plantinga TS, et al. Human dectin-1 deficiency
commensal fungi: a two-way street. Immunity 2015;43(5):845–58. and mucocutaneous fungal infections. N Engl J Med 2009;361(18):
27. van de Veerdonk FL, Joosten LA, Netea MG. The interplay between 1760–7.
inflammasome activation and antifungal host defense. Immunol Rev 39. Drummond RA, Collar AL, Swamydas M, et al. CARD9-dependent
2015;265(1):172–80. neutrophil recruitment protects against fungal invasion of the central
28. Caffrey AK, Obar JJ. Alarmin(g) the innate immune system to invasive nervous system. PLoS Pathog 2015;11(12):e1005293.
fungal infections. Curr Opin Microbiol 2016;32:135–43. 40. Puel A, Doffinger R, Natividad A, et al. Autoantibodies against IL-17A,
29. Netea MG, Latz E, Mills KH, et al. Innate immune memory: a paradigm IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis
shift in understanding host defense. Nat Immunol 2015;16(7):675–9. and autoimmune polyendocrine syndrome type I. J Exp Med 2010;
30. Netea MG, Joosten LA, Latz E, et al. Trained immunity: A program of 207(2):291–7.
innate immune memory in health and disease. Science 41. Gow NA, Netea MG. Medical mycology and fungal immunology: new
2016;352(6284):aaf1098. research perspectives addressing a major world health challenge. Philos
31. Quintin J, Saeed S, Martens JH, et al. Candida albicans infection affords Trans R Soc Lond B Biol Sci 2016;371(1709):pii: 20150462.
protection against reinfection via functional reprogramming of 42. Ma CS, Chew GY, Simpson N, et al. Deficiency of Th17 cells in hyper IgE
monocytes. Cell Host Microbe 2012;12(2):223–32. syndrome due to mutations in STAT3. J Exp Med 2008;205(7):1551–7.
32. Zuniga LA, Jain R, Haines C, et al. Th17 cell development: from the 43. Liu L, Okada S, Kong XF, et al. Gain-of-function human STAT1
cradle to the grave. Immunol Rev 2013;252(1):78–88. mutations impair IL-17 immunity and underlie chronic mucocutaneous
33. Hamad M. Innate and adaptive antifungal immune responses: partners candidiasis. J Exp Med 2011;208(8):1635–48.
on an equal footing. Mycoses 2012;55(3):205–17. 44. van de Veerdonk FL, Plantinga TS, Hoischen A, et al. STAT1 mutations in
34. Clark RA, Malech HL, Gallin JI, et al. Genetic variants of chronic autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med
granulomatous disease: prevalence of deficiencies of two cytosolic 2011;365(1):54–61.
components of the NADPH oxidase system. N Engl J Med 1989; 45. Depner M, Fuchs S, Raabe J, et al. The extended clinical phenotype of 26
321(10):647–52. patients with chronic mucocutaneous candidiasis due to gain-of-function
35. Wang X, van de Veerdonk FL. When the Fight against Fungi Goes Wrong. mutations in STAT1. J Clin Immunol 2016;36(1):73–84.
PLoS Pathog 2016;12(2):e1005400. 46. Okada S, Markle JG, Deenick EK, et al. Immunodeficiencies. Impairment
36. de Luca A, Smeekens SP, Casagrande A, et al. IL-1 receptor blockade of immunity to Candida and Mycobacterium in humans with bi-allelic
restores autophagy and reduces inflammation in chronic granulomatous RORC mutations. Science 2015;349(6248):606–13.
disease in mice and in humans. Proc Natl Acad Sci USA 2014;111(9):
3526–31.